Healthcare provider profile · identity verified

Lisa A Malys, DO

Family Practice · WOOSTER, OH · NPI 1013172121

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	309	62
Omeprazole	Omeprazole	252	54
Duloxetine Hcl	Duloxetine Hcl	204	30
Gabapentin	Gabapentin	195	37
Amlodipine Besylate	Amlodipine Besylate	185	40
Citalopram Hbr	Citalopram Hydrobromide	168	35
Atorvastatin Calcium	Atorvastatin Calcium	158	37
Losartan Potassium	Losartan Potassium	143	32
Hydrochlorothiazide	Hydrochlorothiazide	141	32
Meloxicam	Meloxicam	139	31
Pantoprazole Sodium	Pantoprazole Sodium	136	29
Metoprolol Tartrate	Metoprolol Tartrate	133	24
Albuterol Sulfate Hfa	Albuterol Sulfate	128	28
Lisinopril	Lisinopril	125	32
Simvastatin	Simvastatin	125	32
Furosemide	Furosemide	120	27
Potassium Chloride	Potassium Chloride	119	23
Metoprolol Succinate	Metoprolol Succinate	106	25
Lorazepam	Lorazepam	105	28
Alprazolam	Alprazolam	98	14
Glipizide Er	Glipizide	89	24
Liothyronine Sodium	Liothyronine Sodium	88	19
Metformin Hcl	Metformin Hcl	86	21
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	85	23
Tramadol Hcl	Tramadol Hcl	84	18
Pravastatin Sodium	Pravastatin Sodium	78	20
Sertraline Hcl	Sertraline Hcl	78	17
Oxybutynin Chloride Er	Oxybutynin Chloride	73	11
Escitalopram Oxalate	Escitalopram Oxalate	72	13
Allopurinol	Allopurinol	63	11
Montelukast Sodium	Montelukast Sodium	63	11
Azithromycin	Azithromycin	62	43
Ciprofloxacin Hcl	Ciprofloxacin Hcl	61	34
Atenolol	Atenolol	60	11
Synthroid	Levothyroxine Sodium	59	18
Buspirone Hcl	Buspirone Hcl	55	13
Eliquis	Apixaban	52	12
Prednisone	Prednisone	52	31
Esomeprazole Magnesium	Esomeprazole Magnesium	51	suppressed
Oxycodone Hcl	Oxycodone Hcl	50	14
Famotidine	Famotidine	48	13
Glimepiride	Glimepiride	48	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	47	suppressed
Spironolactone	Spironolactone	47	14
Fluoxetine Hcl	Fluoxetine Hcl	46	11
Trazodone Hcl	Trazodone Hcl	46	12
Carvedilol	Carvedilol	45	13
Clopidogrel	Clopidogrel Bisulfate	45	11
Amitriptyline Hcl	Amitriptyline Hcl	44	suppressed
Paroxetine Hcl	Paroxetine Hcl	44	suppressed
Fluconazole	Fluconazole	43	19
Warfarin Sodium	Warfarin Sodium	42	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	41	suppressed
Metformin Hcl Er	Metformin Hcl	41	12
Diclofenac Sodium	Diclofenac Sodium	40	suppressed
Memantine Hcl	Memantine Hcl	40	suppressed
Ropinirole Hcl	Ropinirole Hcl	40	suppressed
Alendronate Sodium	Alendronate Sodium	39	12
Mirtazapine	Mirtazapine	39	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	39	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	39	suppressed
Pregabalin	Pregabalin	39	suppressed
Tizanidine Hcl	Tizanidine Hcl	38	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	37	suppressed
Aripiprazole	Aripiprazole	35	suppressed
Clonazepam	Clonazepam	35	suppressed
Fluticasone Propionate	Fluticasone Propionate	35	11
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	33	suppressed
Diazepam	Diazepam	33	suppressed
Enulose	Lactulose	33	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	32	19
Cephalexin	Cephalexin	31	12
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	31	suppressed
Meclizine Hcl	Meclizine Hcl	31	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	31	suppressed
Naproxen	Naproxen	30	suppressed
Clonidine Hcl	Clonidine Hcl	28	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	28	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	28	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	28	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	27	suppressed
Ozempic	Semaglutide	26	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	24	suppressed
Lovastatin	Lovastatin	24	suppressed
Metronidazole	Metronidazole	24	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	24	suppressed
Donepezil Hcl	Donepezil Hcl	22	suppressed
Ezetimibe	Ezetimibe	22	suppressed
Jardiance	Empagliflozin	22	suppressed
Levofloxacin	Levofloxacin	22	11
Mounjaro	Tirzepatide	22	suppressed
Temazepam	Temazepam	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Doxepin Hcl	Doxepin Hcl	20	suppressed
Estradiol	Estradiol	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Bupropion Xl	Bupropion Hcl	18	suppressed
Ondansetron Hcl	Ondansetron Hcl	18	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	18	suppressed
Celecoxib	Celecoxib	17	suppressed
Ibu	Ibuprofen	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	17	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	16	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Nabumetone	Nabumetone	16	suppressed
Tradjenta	Linagliptin	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Amoxicillin	Amoxicillin	15	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	15	14
Lansoprazole	Lansoprazole	15	suppressed
Paliperidone Er	Paliperidone	15	suppressed
Colestipol Hcl	Colestipol Hcl	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Olanzapine	Olanzapine	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	12
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	suppressed
Ursodiol	Ursodiol	14	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	suppressed
Methylprednisolone	Methylprednisolone	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Topiramate	Topiramate	13	suppressed
Trandolapril	Trandolapril	13	suppressed
Acetazolamide Er	Acetazolamide	12	suppressed
Fenofibric Acid	Fenofibric Acid (Choline)	12	suppressed
Lubiprostone	Lubiprostone	12	suppressed
Memantine Hcl Er	Memantine Hcl	12	suppressed
Moexipril Hcl	Moexipril Hcl	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Brilinta	Ticagrelor	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	11	suppressed
Glyburide	Glyburide	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Prazosin Hcl	Prazosin Hcl	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error